Epigral Limited submits Transcript of Conference Call held on Friday, 30th January, 2026 for Q3 FY26 Results.
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has submitted to the stock exchanges the transcript of its conference call held on Friday, 30th January 2026, where management discussed the company's Q3 FY26 financial results. The transcript is being shared with investors and analysts for reference. No specific financial numbers, guidance, or management commentary are included in this filing notice itself. The actual content of the call would need to be reviewed from the attached transcript document.
This is a routine compliance filing and is unlikely to have a direct impact on the stock price. Investors should review the attached transcript for any management guidance, outlook commentary, or strategic updates from the Q3 FY26 earnings call.